Is your quality system built for 2026's new regulatory reality?

Delve into the current compliance landscape for life sciences manufacturers and the vulnerabilities found in legacy quality systems. Life science manufacturers must transition from traditional inspection sprints to continuous compliance to navigate converging 2026 regulations. Shutterstock The life sciences industry has always operated under pressure to stay ahead of regulatory change. But 2026 has raised the stakes considerably, bringing not just one significant shift, but several that are converging at the same time, across multiple regulatory frameworks simultaneously. At MasterControl, we work with life sciences manufacturers every day who are grappling with exactly this challenge: quality systems that were designed…

Source: Clinical Trials Arena